Barbara Ann Karmanos Cancer Institute
01/17/2025 | Press release | Archived content
IN THE NEWS: NSCLC Experts Ponder Best First-Line Treatment Options
January 17, 2025
CancerNetwork
Tarik Hadid, M.D., MPH, MS, FACP, medical oncologist and member of the Phase I Clinical Trials and Thoracic Oncology Multidisciplinary Teams at Karmanos, joined the CancerNetwork Satellite Sessions program to discuss the best first-line treatment options for non-small cell lung cancer. The group of oncologists discussed MARIPOSA trials and findings, FLAURA and FLAURA2, helping patients decide on a treatment, how metastasis factors into treatment, and ctDNA analysis and additional testing.
Read the discussion here.
Barbara Ann Karmanos Cancer Institute published this content on January 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 21, 2025 at 13:40 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]